Innate Pharma (IPH.PA) Q1 2025 Earnings

27MarConfirmed
Q1 2024
Q1 2024
Q3 2024
Q1 2025
-0.41
-0.31
-0.22
-0.12

Details

Expected EPS
-0.24440426162400003
Actual EPS
-0.297118906288
Surprise EPS
-0.05
Surprise Percent
+21.57%

Description

Innate Pharma (IPH.PA) has reported earnings of -0.297118906288 per share for Q1 2025.

0 Comments

Share your thoughts